Home > > > Report Detail

Global Insomnia Therapeutics Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 16-Sep-2022
No. of pages: 111
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Insomnia Therapeutics Drugs companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Insomnia Therapeutics Drugs market. Further, it explains the major drivers and regional dynamics of the global Insomnia Therapeutics Drugs market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Takeda Pharmaceutical Company Ltd.

- Vanda Pharmaceuticals

- Merck & Co., Inc.

- Pfizer Inc.

- Teva Pharmaceutical Industries Ltd.

- Mylan N.V.

- Sumitomo Dainippon Pharma Co., Ltd

- Sanofi

- Paratek Pharmaceuticals Inc.

- Ebb Therapeutics

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Insomnia Therapeutics Drugs Segment by Type

- Benzodiazepines

- Nonbenzodiazepines

- Antidepressants

- Orexin Antagonists

- Melatonin Antagonists

- Others

Insomnia Therapeutics Drugs Segment by Application

- Prescription

- Over-the-Counter (OTC)

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Insomnia Therapeutics Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Insomnia Therapeutics Drugs market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Insomnia Therapeutics Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Insomnia Therapeutics Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Insomnia Therapeutics Drugs revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Insomnia Therapeutics Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Insomnia Therapeutics Drugs revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Takeda Pharmaceutical Company Ltd., Vanda Pharmaceuticals, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sumitomo Dainippon Pharma Co., Ltd, Sanofi and Paratek Pharmaceuticals Inc., etc.

Global Insomnia Therapeutics Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Benzodiazepines
1.2.3 Nonbenzodiazepines
1.2.4 Antidepressants
1.2.5 Orexin Antagonists
1.2.6 Melatonin Antagonists
1.2.7 Others
1.3 Market by Application
1.3.1 Global Insomnia Therapeutics Drugs Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Prescription
1.3.3 Over-the-Counter (OTC)
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Insomnia Therapeutics Drugs Market Size (2017-2028)
2.2 Insomnia Therapeutics Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Insomnia Therapeutics Drugs Market Size by Region (2017-2022)
2.4 Global Insomnia Therapeutics Drugs Market Size Forecast by Region (2023-2028)
2.5 Global Top Insomnia Therapeutics Drugs Countries Ranking by Market Size
3 Insomnia Therapeutics Drugs Competitive by Company
3.1 Global Insomnia Therapeutics Drugs Revenue by Players
3.1.1 Global Insomnia Therapeutics Drugs Revenue by Players (2017-2022)
3.1.2 Global Insomnia Therapeutics Drugs Market Share by Players (2017-2022)
3.2 Global Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Insomnia Therapeutics Drugs Revenue
3.4 Global Insomnia Therapeutics Drugs Market Concentration Ratio
3.4.1 Global Insomnia Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapeutics Drugs Revenue in 2021
3.5 Global Insomnia Therapeutics Drugs Key Players Head office and Area Served
3.6 Key Players Insomnia Therapeutics Drugs Product Solution and Service
3.7 Date of Enter into Insomnia Therapeutics Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Insomnia Therapeutics Drugs Breakdown Data by Type
4.1 Global Insomnia Therapeutics Drugs Historic Revenue by Type (2017-2022)
4.2 Global Insomnia Therapeutics Drugs Forecasted Revenue by Type (2023-2028)
5 Global Insomnia Therapeutics Drugs Breakdown Data by Application
5.1 Global Insomnia Therapeutics Drugs Historic Market Size by Application (2017-2022)
5.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Insomnia Therapeutics Drugs Revenue by Company (2020-2022)
6.2 North America Insomnia Therapeutics Drugs Revenue by Type (2017-2028)
6.3 North America Insomnia Therapeutics Drugs Revenue by Application (2017-2028)
6.4 North America Insomnia Therapeutics Drugs Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Insomnia Therapeutics Drugs Revenue by Company (2020-2022)
7.2 Europe Insomnia Therapeutics Drugs Revenue by Type (2017-2028)
7.3 Europe Insomnia Therapeutics Drugs Revenue by Application (2017-2028)
7.4 Europe Insomnia Therapeutics Drugs Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Insomnia Therapeutics Drugs Revenue by Company (2020-2022)
8.2 Asia Pacific Insomnia Therapeutics Drugs Revenue by Type (2017-2028)
8.3 Asia Pacific Insomnia Therapeutics Drugs Revenue by Application (2017-2028)
8.4 Asia Pacific Insomnia Therapeutics Drugs Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Insomnia Therapeutics Drugs Revenue by Company (2020-2022)
9.2 Latin America Insomnia Therapeutics Drugs Revenue by Type (2017-2028)
9.3 Latin America Insomnia Therapeutics Drugs Revenue by Application (2017-2028)
9.4 Latin America Insomnia Therapeutics Drugs Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Insomnia Therapeutics Drugs Revenue by Company (2020-2022)
10.2 Middle East and Africa Insomnia Therapeutics Drugs Revenue by Type (2017-2028)
10.3 Middle East and Africa Insomnia Therapeutics Drugs Revenue by Application (2017-2028)
10.4 Middle East and Africa Insomnia Therapeutics Drugs Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Takeda Pharmaceutical Company Ltd.
11.1.1 Takeda Pharmaceutical Company Ltd. Company Details
11.1.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Products and Services
11.1.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.1.5 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs SWOT Analysis
11.1.6 Takeda Pharmaceutical Company Ltd. Recent Developments
11.2 Vanda Pharmaceuticals
11.2.1 Vanda Pharmaceuticals Company Details
11.2.2 Vanda Pharmaceuticals Business Overview
11.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Products and Services
11.2.4 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.2.5 Vanda Pharmaceuticals Insomnia Therapeutics Drugs SWOT Analysis
11.2.6 Vanda Pharmaceuticals Recent Developments
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Company Details
11.3.2 Merck & Co., Inc. Business Overview
11.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Products and Services
11.3.4 Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.3.5 Merck & Co., Inc. Insomnia Therapeutics Drugs SWOT Analysis
11.3.6 Merck & Co., Inc. Recent Developments
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Details
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Products and Services
11.4.4 Pfizer Inc. Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.4.5 Pfizer Inc. Insomnia Therapeutics Drugs SWOT Analysis
11.4.6 Pfizer Inc. Recent Developments
11.5 Teva Pharmaceutical Industries Ltd.
11.5.1 Teva Pharmaceutical Industries Ltd. Company Details
11.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Products and Services
11.5.4 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.5.5 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs SWOT Analysis
11.5.6 Teva Pharmaceutical Industries Ltd. Recent Developments
11.6 Mylan N.V.
11.6.1 Mylan N.V. Company Details
11.6.2 Mylan N.V. Business Overview
11.6.3 Mylan N.V. Insomnia Therapeutics Drugs Products and Services
11.6.4 Mylan N.V. Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.6.5 Mylan N.V. Insomnia Therapeutics Drugs SWOT Analysis
11.6.6 Mylan N.V. Recent Developments
11.7 Sumitomo Dainippon Pharma Co., Ltd
11.7.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
11.7.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Products and Services
11.7.4 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.7.5 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs SWOT Analysis
11.7.6 Sumitomo Dainippon Pharma Co., Ltd Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Insomnia Therapeutics Drugs Products and Services
11.8.4 Sanofi Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.8.5 Sanofi Insomnia Therapeutics Drugs SWOT Analysis
11.8.6 Sanofi Recent Developments
11.9 Paratek Pharmaceuticals Inc.
11.9.1 Paratek Pharmaceuticals Inc. Company Details
11.9.2 Paratek Pharmaceuticals Inc. Business Overview
11.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Products and Services
11.9.4 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.9.5 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs SWOT Analysis
11.9.6 Paratek Pharmaceuticals Inc. Recent Developments
11.10 Ebb Therapeutics
11.10.1 Ebb Therapeutics Company Details
11.10.2 Ebb Therapeutics Business Overview
11.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Products and Services
11.10.4 Ebb Therapeutics Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
11.10.5 Ebb Therapeutics Insomnia Therapeutics Drugs SWOT Analysis
11.10.6 Ebb Therapeutics Recent Developments
12 Insomnia Therapeutics Drugs Market Dynamics
12.1 Insomnia Therapeutics Drugs Market Trends
12.2 Insomnia Therapeutics Drugs Market Drivers
12.3 Insomnia Therapeutics Drugs Market Challenges
12.4 Insomnia Therapeutics Drugs Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Benzodiazepines
Table 3. Key Players of Nonbenzodiazepines
Table 4. Key Players of Antidepressants
Table 5. Key Players of Orexin Antagonists
Table 6. Key Players of Melatonin Antagonists
Table 7. Key Players of Others
Table 8. Global Insomnia Therapeutics Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Insomnia Therapeutics Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 10. Global Insomnia Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Insomnia Therapeutics Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Insomnia Therapeutics Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 13. Global Insomnia Therapeutics Drugs Market Share by Players (2017-2022)
Table 14. Global Top Insomnia Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2021)
Table 15. Ranking of Global Top Insomnia Therapeutics Drugs Companies by Revenue (US$ Million) in 2021
Table 16. Global 5 Largest Players Market Share by Insomnia Therapeutics Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 17. Key Players Headquarters and Area Served
Table 18. Key Players Insomnia Therapeutics Drugs Product Solution and Service
Table 19. Date of Key Manufacturers Enter into Insomnia Therapeutics Drugs Market
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Insomnia Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 22. Global Insomnia Therapeutics Drugs Revenue Market Share by Type (2017-2022)
Table 23. Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 24. Global Insomnia Therapeutics Drugs Revenue Market Share by Type (2023-2028)
Table 25. Global Insomnia Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 26. Global Insomnia Therapeutics Drugs Revenue Market Share by Application (2017-2022)
Table 27. Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 28. Global Insomnia Therapeutics Drugs Revenue Market Share by Application (2023-2028)
Table 29. North America Insomnia Therapeutics Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 30. North America Insomnia Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 31. North America Insomnia Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 32. North America Insomnia Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 33. North America Insomnia Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 34. North America Insomnia Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 35. North America Insomnia Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 36. Europe Insomnia Therapeutics Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 37. Europe Insomnia Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 38. Europe Insomnia Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 39. Europe Insomnia Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 40. Europe Insomnia Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 41. Europe Insomnia Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 42. Europe Insomnia Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Insomnia Therapeutics Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 44. Asia Pacific Insomnia Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Insomnia Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Insomnia Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Insomnia Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Insomnia Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Insomnia Therapeutics Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 50. Latin America Insomnia Therapeutics Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 51. Latin America Insomnia Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 52. Latin America Insomnia Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 53. Latin America Insomnia Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 54. Latin America Insomnia Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 55. Latin America Insomnia Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 56. Latin America Insomnia Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Insomnia Therapeutics Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 58. Middle East and Africa Insomnia Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Insomnia Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Insomnia Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Insomnia Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Insomnia Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Insomnia Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 64. Takeda Pharmaceutical Company Ltd. Company Details
Table 65. Takeda Pharmaceutical Company Ltd. Business Overview
Table 66. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product and Services
Table 67. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 68. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs SWOT Analysis
Table 69. Takeda Pharmaceutical Company Ltd. Recent Developments
Table 70. Vanda Pharmaceuticals Company Details
Table 71. Vanda Pharmaceuticals Business Overview
Table 72. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product and Services
Table 73. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 74. Vanda Pharmaceuticals Insomnia Therapeutics Drugs SWOT Analysis
Table 75. Vanda Pharmaceuticals Recent Developments
Table 76. Merck & Co., Inc. Company Details
Table 77. Merck & Co., Inc. Business Overview
Table 78. Merck & Co., Inc. Insomnia Therapeutics Drugs Product and Services
Table 79. Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 80. Merck & Co., Inc. Insomnia Therapeutics Drugs SWOT Analysis
Table 81. Merck & Co., Inc. Recent Developments
Table 82. Pfizer Inc. Company Details
Table 83. Pfizer Inc. Business Overview
Table 84. Pfizer Inc. Insomnia Therapeutics Drugs Product and Services
Table 85. Pfizer Inc. Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 86. Pfizer Inc. Insomnia Therapeutics Drugs SWOT Analysis
Table 87. Pfizer Inc. Recent Developments
Table 88. Teva Pharmaceutical Industries Ltd. Company Details
Table 89. Teva Pharmaceutical Industries Ltd. Business Overview
Table 90. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product and Services
Table 91. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 92. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs SWOT Analysis
Table 93. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 94. Mylan N.V. Company Details
Table 95. Mylan N.V. Business Overview
Table 96. Mylan N.V. Insomnia Therapeutics Drugs Product and Services
Table 97. Mylan N.V. Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 98. Mylan N.V. Insomnia Therapeutics Drugs SWOT Analysis
Table 99. Mylan N.V. Recent Developments
Table 100. Sumitomo Dainippon Pharma Co., Ltd Company Details
Table 101. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 102. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product and Services
Table 103. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 104. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs SWOT Analysis
Table 105. Sumitomo Dainippon Pharma Co., Ltd Recent Developments
Table 106. Sanofi Company Details
Table 107. Sanofi Business Overview
Table 108. Sanofi Insomnia Therapeutics Drugs Product and Services
Table 109. Sanofi Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 110. Sanofi Insomnia Therapeutics Drugs SWOT Analysis
Table 111. Sanofi Recent Developments
Table 112. Paratek Pharmaceuticals Inc. Company Details
Table 113. Paratek Pharmaceuticals Inc. Business Overview
Table 114. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product and Services
Table 115. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 116. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs SWOT Analysis
Table 117. Paratek Pharmaceuticals Inc. Recent Developments
Table 118. Ebb Therapeutics Company Details
Table 119. Ebb Therapeutics Business Overview
Table 120. Ebb Therapeutics Insomnia Therapeutics Drugs Product and Services
Table 121. Ebb Therapeutics Insomnia Therapeutics Drugs Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 122. Ebb Therapeutics Insomnia Therapeutics Drugs SWOT Analysis
Table 123. Ebb Therapeutics Recent Developments
Table 124. Insomnia Therapeutics Drugs Market Trends
Table 125. Insomnia Therapeutics Drugs Market Drivers
Table 126. Insomnia Therapeutics Drugs Market Challenges
Table 127. Insomnia Therapeutics Drugs Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Insomnia Therapeutics Drugs Sales Market Share by Type: 2021 VS 2028
Figure 2. Benzodiazepines Features
Figure 3. Nonbenzodiazepines Features
Figure 4. Antidepressants Features
Figure 5. Orexin Antagonists Features
Figure 6. Melatonin Antagonists Features
Figure 7. Others Features
Figure 8. Global Insomnia Therapeutics Drugs Sales Market Share by Application: 2021 VS 2028
Figure 9. Prescription Case Studies
Figure 10. Over-the-Counter (OTC) Case Studies
Figure 11. Insomnia Therapeutics Drugs Report Years Considered
Figure 12. Global Insomnia Therapeutics Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Insomnia Therapeutics Drugs Market Size 2017-2028 (US$ Million)
Figure 14. Global Insomnia Therapeutics Drugs Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Insomnia Therapeutics Drugs Revenue Market Share by Region in 2017 VS 2022
Figure 16. Global Top 10 Insomnia Therapeutics Drugs Countries Ranking by Market Size (US$ Million) in 2021
Figure 17. Global Insomnia Therapeutics Drugs Market Share by Players in 2021
Figure 18. Global Top Insomnia Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Insomnia Therapeutics Drugs Revenue in 2021
Figure 20. North America Insomnia Therapeutics Drugs Revenue Market Share by Company in 2021
Figure 21. North America Insomnia Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 22. North America Insomnia Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 23. North America Insomnia Therapeutics Drugs Revenue Share by Country (2017-2028)
Figure 24. U.S. Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 25. Canada Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 26. Europe Insomnia Therapeutics Drugs Revenue Market Share by Company in 2021
Figure 27. Europe Insomnia Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 28. Europe Insomnia Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 29. Europe Insomnia Therapeutics Drugs Revenue Share by Country (2017-2028)
Figure 30. Germany Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 31. France Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 32. U.K. Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 33. Italy Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 34. Russia Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Insomnia Therapeutics Drugs Revenue Market Share by Company in 2021
Figure 36. Asia Pacific Insomnia Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 37. Asia Pacific Insomnia Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 38. Asia Pacific Insomnia Therapeutics Drugs Revenue Share by Region (2017-2028)
Figure 39. China Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. Japan Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. South Korea Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. India Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 43. Australia Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 44. Taiwan Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 45. Indonesia Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 46. Thailand Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 47. Malaysia Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. Philippines Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. Vietnam Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. Latin America Insomnia Therapeutics Drugs Revenue Market Share by Company in 2021
Figure 51. Latin America Insomnia Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 52. Latin America Insomnia Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 53. Latin America Insomnia Therapeutics Drugs Revenue Share by Country (2017-2028)
Figure 54. Mexico Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. Brazil Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. Argentina Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. Middle East and Africa Insomnia Therapeutics Drugs Revenue Market Share by Company in 2021
Figure 58. Middle East and Africa Insomnia Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 59. Middle East and Africa Insomnia Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 60. Middle East and Africa Insomnia Therapeutics Drugs Revenue Share by Country (2017-2028)
Figure 61. Turkey Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Saudi Arabia Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. UAE Insomnia Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 65. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 66. Merck & Co., Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 67. Pfizer Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 68. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 69. Mylan N.V. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 70. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 71. Sanofi Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 72. Paratek Pharmaceuticals Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 73. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs